The impact of human epidermal growth factor receptor-2 status of invasive breast tumors on thermography findings

被引:0
|
作者
Zore, Zvonimir [1 ]
Boras, Ivanka [2 ]
Filipovic-Zore, Irina [3 ]
Stanec, Mladen [1 ]
Lesar, Miroslav [1 ]
Vrdoljak, Danko V. [1 ]
机构
[1] Univ Clin Hosp Ctr, Dept Surg Oncol, Zagreb 197, Croatia
[2] Univ Sch Mech Engn & Naval Architecture, Dept Thermodynam, Zagreb, Croatia
[3] Univ Zagreb, Sch Dent Med, Dept Oral Surg, Zagreb 41000, Croatia
关键词
CANCER;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyze the impact of the prognostic human epidermal growth factor receptor-2 (HER-2) in invasive breast cancers on the findings of thermography tests. Methods: This study was carried out at the Department of Surgical Oncology and the Department of Pathology, University Clinical Hospital Center, "Sisters of Mercy", Zagreb, Croatia, in collaboration with licensed infrared (IR) thermography experts. The study involved 75 female patients diagnosed with invasive breast cancer from May to July 2011. Thermography findings were compared between different immune-histochemical (IHC) findings (HER-2 status: positive or negative). Results: Significantly higher temperatures were recorded in invasive cancer breasts than in healthy breasts. The cancer sites and the entire cancer breasts were significantly warmer (p<0.001) than the healthy breasts and opposite tumors mirror sites. Considering the HER-2 status, HER-2 positive invasive cancers were significantly warmer in comparison with the HER-2 negative cancers (p=0.035). Conclusion: The trend of increased temperature in HER-2+ tumors was noted. The findings clearly indicate that HER-2+ status has a higher impact on the increased thermographic temperature findings. Saudi Med J 2012; Vol. 33 (10): 1118-1121
引用
收藏
页码:1118 / 1121
页数:4
相关论文
共 50 条
  • [1] Human epidermal growth factor receptor 2 status in breast cancer: A comparison between borderline positive human epidermal growth factor receptor 2 and strongly positive human epidermal growth factor receptor 2 tumors
    Huszno, Joanna
    Nowara, Elibieta
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (03): : 307 - 311
  • [2] Advances in Variations of Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor-2 Status in Metastatic Breast Cancer
    Yuan Yuan
    Zhang Lili
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (02): : 55 - 60
  • [3] The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer
    Wang, Jane
    Shih, Tiffany Ting-Fang
    Yen, Ruoh-Fang
    Lu, Yen-Shen
    Chen, Chin-Yu
    Mao, Tsui-Lien
    Lin, Ching-Hung
    Kuo, Wen-Hung
    Tsai, Yuh-Show
    Chang, King-Jen
    Chien, Kuo-Liong
    ACADEMIC RADIOLOGY, 2011, 18 (02) : 212 - 219
  • [4] An Audit of Hormone Receptor and Human Epidermal Growth Factor Receptor-2 (HER2) Status in Breast Carcinoma Metastatic to Bone
    Gardner, K.
    Loane, J.
    JOURNAL OF PATHOLOGY, 2021, 255 : S44 - S44
  • [5] Human epidermal growth factor receptor-2 (HER-2) expression status in patients with cholangiocarcinoma
    Imemkamon, T.
    Sa-ngiamwiboon, P.
    Wirasorn, K.
    ANNALS OF ONCOLOGY, 2022, 33 : S1478 - S1478
  • [6] Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer
    Abunada, Aya
    Sirhan, Zaid
    Thyagarajan, Anita
    Sahu, Ravi P.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2023, 14 (05): : 198 - 202
  • [7] Association of Human Epidermal Growth Factor Receptor-2 Expression and Clinicopathological Findings in Patients with Colorectal Cancer
    Karaca, Halit
    Deniz, Kemal
    Berk, Veli
    Inanc, Mevlude
    Ozkan, Metin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 6221 - 6225
  • [8] Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings
    Molaei, Mahsa
    Pejhan, Shervin
    Nayer, Babak Noori
    Moradi, Afshin
    Ghiasi, Somaye
    Zali, Mohamad Reza
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : 289 - 293
  • [9] Validation of human epidermal growth factor receptor 2 status evaluation in invasive breast cancer biopsies on clinical setting
    Moreno, F.
    Coelho, A.
    Vizcaino, R.
    VIRCHOWS ARCHIV, 2014, 465 : S19 - S20
  • [10] Human epidermal growth factor receptor-2 and endocrine resistance in hormone-dependent breast cancer
    Alataki, Anastasia
    Dowsett, Mitch
    ENDOCRINE-RELATED CANCER, 2022, 29 (08) : R105 - R122